The pharmaceutical dosage market in Vietnam experienced a steady increase from 2013 to 2023, reaching $6.3216 billion in 2023. The year-on-year growth has varied, experiencing high growth in 2015 at 9.59% and a dip in 2018 at -3.26%. The market growth rate recovered and maintained a steady increase, with a 4.48% rise from 2022 to 2023. The compound annual growth rate (CAGR) over the last five years (2018-2023) was 4.47%, demonstrating moderate but consistent expansion.
Looking ahead, the market forecasted for 2028 predicts continued growth, reaching $7.6374 billion by 2028. Over the next five years, the forecasted CAGR is 2.99%, indicating a slightly slower but stable increase. Expected total growth over this period is 15.89%.
Future trends to watch in the Vietnamese pharmaceutical dosage market include:
- Increased demand for chronic disease treatments due to an aging population.
- Expansion of healthcare infrastructure and accessibility.
- Governmental policies and initiatives aimed at boosting domestic pharmaceutical production.
- Advancements in pharmaceutical technology and innovation.
- Impact of global economic factors and trade policies.
